Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma

Genes Chromosomes and Cancer

Volumn 50, Issue 11, 2011, Pages 908-921

  Kuo, Sung Hsin ^a,b   Weng, Wen Hui ^c   Chen, Zi Hua ^c,d   Hsu, Ping Ning ^a   Wu, Ming Shiang ^a   Lin, Chung Wu ^a   Jeng, Huei Jiuan ^a,b   Yeh, Kun Huei ^a,b   Tsai, Hui Jen ^e,f   Chen, Li Tzong ^e,f,g   Cheng, Ann Lii ^a,b,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d MING CHUAN UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CHLORAMBUCIL; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; OMEPRAZOLE; PREDNISOLONE; PROTEIN; PROTEIN BCL 10; PROTEIN CRAD9; RITUXIMAB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CASE REPORT; CELL STRUCTURE; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; COMPARATIVE GENOMIC HYBRIDIZATION; DIPLOIDY; DISEASE FREE SURVIVAL; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPIGASTRIC PAIN; ERADICATION THERAPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE AMPLIFICATION; GENE DOSAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KARYOTYPE 46,XY; KARYOTYPING; LYMPHADENOPATHY; LYMPHOMA CELL LINE; MONOTHERAPY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PRIORITY JOURNAL; STOMACH LYMPHOMA; STRUCTURAL CHROMOSOME ABERRATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR RECURRENCE; WALDEYER RING;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; COMPARATIVE GENOMIC HYBRIDIZATION; FLOW CYTOMETRY; GENE DOSAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, NON-HODGKIN; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SPECTRAL KARYOTYPING; STOMACH NEOPLASMS; TRANSLOCATION, GENETIC;

HELICOBACTER PYLORI;

EID: 80052682676     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20910     Document Type: Article

References (55)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. 1997. The Non-Hodgkin's Lymphoma Classification Project. Blood 89: 3909-3918.
2. Amini RM, Berglund M, Rosenquist R, Von Heideman A, Lagercrantz S, Thunberg U, Bergh J, Sundström C, Glimelius B, Enblad G. 2002. A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. Leuk Lymphoma 43: 2179-2189.
3. Au WY, Pang A, Choy C, Chim CS, Kwong YL. 2004. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104: 243-249.
4. Bacon CM, Du MQ, Dogan A. 2007. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists. J Clin Pathol 60: 361-372.
5. Bertin J, Guo Y, Wang L, Srinivasula SM, Jacobson MD, Poyet JL, Merriam S, Du MQ, Dyer MJ, Robison KE, DiStefano PS, Alnemri ES. 2000. CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-κB. J Biol Chem 275: 41082-41086.
6. Chen ZJ. 2005. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758-765.
7. Drexler HG. 2010. Guide to Leukemia-lymphoma cell Lines, 2nd ed. Braunschweig, Germany [ebook on compact disk].
8. Du MQ. 2007. MALT lymphoma: Recent advances in aetiology and molecular genetics. J Clin Exp Hematop 47: 31-42.
9. Du MQ. 2011. MALT lymphoma: Many roads lead to nuclear factor-κB activation. Histopathology 58: 26-38.
10. Du MQ, Isaccson PG. 2002. Gastric MALT lymphoma: From aetiology to treatment. Lancet Oncol 3: 97-104.
11. Du MQ, Atherton JC. 2006. Molecular subtyping of gastric MALT lymphomas: Implications for prognosis and management. Gut 55: 886-893.
12. Ferry JA, Yang WI, Zukerberg LR, Wotherspoon AC, Arnold A, Harris NL. 1996. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol 105: 31-37.
13. Greiner A, Knorr C, Qin Y, Sebald W, Schimpl A, Banchereau J, Müller-Hermelink HK. 1997. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol 150: 1583-1593.
14. Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, Förster I, Ruland J. 2006. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442: 651-656.
15. Hamoudi RA, Appert A, Ye H, Ruskone-Fourmestraux A, Streubel B, Chott A, Raderer M, Gong L, Wlodarska I, De Wolf-Peeters C, MacLennan KA, de Leval L, Isaacson PG, Du MQ. 2010. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: Insights into molecular mechanism. Leukemia 24: 1487-1497.
16. Hsu YM, Zhang Y, You Y, Wang D, Li H, Duramad O, Qin XF, Dong C, Lin X. 2007. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol 8: 198-205.
17. Hussell T, Isaacson PG, Crabtree JE, Spencer J. 1993. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342: 571-574.
18. Hussell T, Isaacson PG, Crabtree JE, Spencer J. 1996. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178: 122-127.
19. Isaacson PG. 1999. Gastric MALT lymphoma: From concept to cure. Ann Oncol 10: 637-645.
20. Isaacson PG, Du MQ. 2005. Gastrointestinal lymphoma: Where morphology meets molecular biology. J Pathol 205: 255-274.
21. Isaacson PG, Wotherspoon AC, Diss T, Pan LX. 1991. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol 15: 819-828.
22. Kaleem Z, White G, Vollmer RT. 2001. Critical analysis and diagnostic usefulness of limited immunophenotyping of B-cell non-Hodgkin lymphomas by flow cytometry. Am J Clin Pathol 115: 136-142.
23. Kang MR, Kim MS, Kim SS, Ahn CH, Yoo NJ, Lee SH. 2009. NF-κB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas. Pathology 41: 622-625.
24. Kuo SH, Chen LT, Yeh KH, Wu MS, Hsu HC, Yeh PY, Mao TL, Chen CL, Doong SL, Lin JT, Cheng AL. 2004. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 22: 3491-3497.
25. Kuo SH, Chen LT, Wu MS, Kuo KT, Yeh KH, Doong SL, Yeh PY, Hsu HC, Tzeng YS, Lin CW, Lin JT, Cheng AL. 2007. Differential response to H pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significant association with clonality and BCL10 expression of the tumor cells. J Pathol 211: 296-304.
26. Kuo SH, Yeh PY, Chen LT, Wu MS, Lin CW, Yeh KH, Tzeng YS, Chen JY, Hsu PN, Lin JT, Cheng AL. 2008. Overexpression of B-cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma. Blood 112: 2927-2934.
27. Li Z, Wang H, Xue L, Shin DM, Roopenian D, Xu W, Qi CF, Sangster MY, Orihuela CJ, Tuomanen E, Rehg JE, Cui X, Zhang Q, Morse HC III, Morris SW. 2009. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-κB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma. Blood 114: 4158-4168.
28. Libra M, De Re V, Gloghini A, Gasparotto D, Gragnani L, Navolanic PM, De Vita S, Mazzarino MC, Zignego AL, Carbone A, Boiocchi M. 2004. Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection. Haematologica 89: 873-874.
29. Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG, Du MQ. 2001. t(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 98: 1182-1187.
30. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ. 2002. t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122: 1286-1294.
31. MacLeod RA, Kaufmann M, Drexler HG. 2007. Cytogenetic harvesting of commonly used tumor cell lines. Nat Protoc 2: 372-382.
32. Murga Penas EM, Callet-Bauchu E, Ye H, Gazzo S, Berger F, Schilling G, Albert-Konetzny N, Vettorazzi E, Salles G, Wlodarska I, Du MQ, Bokemeyer C, Dierlamm J. 2010. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma. Blood 115: 2214-2219.
33. Nakagawa M, Seto M, Hosokawa Y. 2006. Molecular pathogenesis of MALT lymphoma: Two signaling pathways underlying the antiapoptotic effect of API2-MALT1fusion protein. Leukemia 20: 929-936.
34. Nakamura S, Ye H, Bacon CM, Goatly A, Liu H, Banham AH, Ventura R, Matsumoto T, Iida M, Ohji Y, Yao T, Tsuneyoshi M, Du MQ. 2007a. Clinical impact of genetic aberrations in gastric MALT lymphoma: A comprehensive analysis using interphase fluorescence in situ hybridisation. Gut 56: 1358-1363.
35. Nakamura S, Ye H, Bacon CM, Liu H, Goatly A, Matsumoto T, Koga H, Umeno J, Ohji Y, Yao T, Nakahara T, Iida M, Du MQ. 2007b. Gastric MALT lymphoma with t(14;18)(q32;q21) involving IGH and BCL2 genes that responded to Helicobacter pylori eradication. J Clin Pathol 60: 1171-1173.
36. Palmedo G, Hantschke M, Rütten A, Mentzel T, Kempf W, Tomasini D, Kutzner H. 2007. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: An indicator for clonal transformation towards higher-grade B-cell lymphoma? Am J Dermatopathol 29: 231-236.
37. Remstein ED, Kurtin PJ, James CD, Wang XY, Meyer RG, Dewald GW. 2002. Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol 161: 63-71.
38. Remstein ED, Dogan A, Einerson RR, Paternoster SF, Fink SR, Law M, Dewald GW, Kurtin PJ. 2006. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 30: 1546-1553.
39. Sanchez-Izquierdo D, Buchonnet G, Siebert R, Gascoyne RD, Climent J, Karran L, Marin M, Blesa D, Horsman D, Rosenwald A, Staudt LM, Albertson DG, Du MQ, Ye H, Marynen P, Garcia-Conde J, Pinkel D, Dyer MJ, Martinez-Climent JA. 2003. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 101: 4539-4546.
40. Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G, Raderer M, Chott A. 2003. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101: 2335-2339.
41. Streubel B, Simonitsch-Klupp I, Mullauer L, Lamprecht A, Huber D, Siebert R, Stolte M, Trautinger F, Lukas J, Püspök A, Formanek M, Assanasen T, Müller-Hermelink HK, Cerroni L, Raderer M, Chott A. 2004. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 18: 1722-1726.
42. Vasilcanu D, Weng WH, Girnita A, Lui WO, Vasilcanu R, Axelson M, Larsson O, Larsson C, Girnita L. 2006. The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection. Oncogene 25: 3186-3195.
43. Vinatzer U, Gollinger M, Müllauer L, Raderer M, Chott A, Streubel B. 2008. Mucosa-associated lymphoid tissue lymphoma: Novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3. Clin Cancer Res 14: 6426-6431.
44. Weng WH, Ahlén J, Lui WO, Brosjö O, Pang ST, Von Rosen A, Auer G, Larsson O, Larsson C. 2003. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. Br J Cancer 89: 720-726.
45. Wenzel C, Dieckmann K, Fiebiger W, Mannhalter C, Chott A, Raderer M. 2001. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour. Leuk Lymphoma 42: 823-829.
46. Willis TG, Dyer MJS. 2000. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 96: 808-822.
47. Xu Y, McKenna RW, Kroft SH. 2002. Assessment of CD10 in the diagnosis of small B-cell lymphomas: A multiparameter flow cytometric study. Am J Clin Pathol 117: 291-300.
48. Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L, Chott A, Streubel B, Siebert R, Gesk S, Martin-Subero JI, Radford JA, Banerjee S, Nicholson AG, Ranaldi R, Remstein ED, Gao Z, Zheng J, Isaacson PG, Dogan A, Du MQ. 2005. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol 205: 293-301.
49. Ye H, Gong L, Liu H, Ruskone-Fourmestraux A, de Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wündisch T, Molina T, Taal BG, Elena S, Neubauer A, Maclennan KA, Siebert R, Remstein ED, Dogan A, Du MQ. 2006. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H. pylori eradication. Gut 55: 137-138.
50. Yeh KH, Kuo SH, Chen LT, Mao TL, Doong SL, Wu MS, Hsu HC, Tzeng YS, Chen CL, Lin JT, Cheng AL. 2005. Nuclear expression of BCL10 or nuclear factor κB helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21, q21). Blood 106: 1037-1041.
51. Yoneda T, Imaizumi K, Maeda M, Yui D, Manabe T, Katayama T, Sato N, Gomi F, Morihara T, Mori Y, Miyoshi K, Hitomi J, Ugawa S, Yamada S, Okabe M, Tohyama M. 2000. Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein. J Biol Chem 275: 11114-11120.
52. Zhou Y, Ye H, Martin-Subero JI, Hamoudi R, Lu YJ, Wang R, Siebert R, Shipley J, Isaacson PG, Dogan A, Du MQ. 2006. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br J Haematol 1: 35-42.
53. Zhou Y, Ye H, Martin-Subero JI, Gesk S, Hamoudi R, Lu YJ, Wang R, Shipley J, Siebert R, Isaacson PG, Dogan A, Du MQ. 2007. The pattern of genomic gains in salivary gland MALT lymphomas. Haematologica 92: 921-927.
54. Zucca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E, Biondi A, Cavalli F. 1998. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 338: 804-810.
55. Zucca E, Bertoni F, Stathis A, Cavalli F. 2008. Marginal zone lymphomas. Hematol Oncol Clin North Am 22: 883-901.